Colorectal CancerECLIPSENCT04136002
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
An observational study of Colorectal Cancer, run by Guardant Health, Inc. at 271 sites in United States.
Trial summary
The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a… Read more about this study
- Who is it for?
- Ages 45 to 84 yearsHealthy volunteers can take part
- Conditions the study is for
- Colorectal Cancer
- How many people
- 44,467 participants
- Where
- 271 sitesUnited States
- Study dates
- 8 Oct 2019to 5 Aug 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 84 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Single cohort of patients aged between 45 and 84, with no known high risk features, undergoing routine colorectal cancer screening as standard of care.
Who may be able to join
- Subjects aged 45-84 years at time of consent
- Intended to undergo screening colonoscopy
- Considered by a physician or healthcare provider as being of 'average risk' for CRC
- Willing to consent to blood draw pre-bowel preparation administration prior to undergoing colonoscopy within 60 days of the date of the investigational blood draw
- Willing to consent to follow-up for two years as per protocol
Who cannot join
- Undergoing colonoscopy for investigation of symptoms
- Has undergone colonoscopy within preceding 9 years
- Positive FIT/FOBT result within the previous 6 months
- Has completed Cologuard or Epi proColon testing within the previous 3 years
- History of colorectal cancer
- History of any malignancy (patients who have undergone surgical removal of skin squamous cell cancer may be enrolled provided the procedure was completed at least 12 months prior to the date of provision of informed consent for the study)
Show all 13Show fewer
- Known diagnosis of inflammatory bowel disease
- Currently taking any anti-neoplastic or disease-modifying anti-rheumatic drugs (DMARDs)
- Positive family history of colorectal cancer, defined as having one or more first- degree relatives (parent, sibling, or child) with CRC at any age
- Known hereditary/germline risk of colorectal cancer (for example, Lynch syndrome or Hereditary Non-Polyposis CRC [HNPCC], or Familial Adenomatous Polyposis [FAP])
- Any major physical trauma (e.g. disruption of tissue, surgery, organ transplant, blood product transfusion) within the 30 days leading up to the provision of informed consent
- Known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
- Participation in a clinical research study in which an experimental medication has been administered or may be administered within the 30 days leading up to providing informed consent or may be administered through the time of colonoscopy
Trial locations and contacts
271 sites in 1 country.
271 sites in 1 country
United States271 sites
Lovelace Scientific Resources, Inc.
Albuquerque, New Mexico, 87108
Eastern Pennsylvania GI & Liver Specialists
Allentown, Pennsylvania, 18104
US Digestive Health at Blair
Altoona, Pennsylvania, 16602
Associated Gastroenterology Medical Group
Anaheim, California, 92801
University of Michigan
Ann Arbor, Michigan, 48109
Pinnacle Research Group, LLC
Anniston, Alabama, 36207
InSite Digestive Health Care
Arcadia, California, 91006
Digestive Health Partners
Asheville, North Carolina, 28801
Digestive Health Care of Georgia
Atlanta, Georgia, 30309
Emory University School of Medicine
Atlanta, Georgia, 30322
Metro Atlanta Gastroenterology, LLC.
Atlanta, Georgia, 30342
Elligo Clinical Research Center
Austin, Tennessee, 78738
Innovative Medical Research of South Florida, Inc.
Aventura, Florida, 33180
Gastroenterology Associates of Cleveland
Beachwood, Ohio, 44122
Valley Gastroenterology Associates
Beaver Falls, Pennsylvania, 15010
Dayton Gastroenterology, Inc.
Beavercreek, Ohio, 45440
Dayton Gastroenterology
Beavercreek, Ohio, 45440
Washington Gastroenterology
Bellevue, Washington, 98004
Hassman Research Institute
Berlin, New Jersey, 08009
Progressive Clinical Research
Bountiful, Utah, 84010
Reciomed Clinical Research Network, Inc.
Boynton Beach, Florida, 33472
Allied Health Clinical Research Organization, LLC
Brick, New Jersey, 08724
Gastroenterology Associates of Fairfield County
Bridgeport, Connecticut, 06606
Sam Moskowitz, MD
Brooklyn, New York, 11234
NY Scientific
Brooklyn, New York, 11235
Gastroenterology
Burlingame, California, 94010
Ventura County Gastroenterology Medical Group
Camarillo, California, 93012
Associated Gastroenterologists of Central New York, Camillus
Camillus, New York, 13031
Susquehanna Research Group, LLC
Camp Hill, Pennsylvania, 17011
Hope Clinical Research
Canoga Park, California, 91303
Alliance Research Institute
Canoga Park, California, 91304
Cary Gastro Associates
Cary, North Carolina, 27518
Christie Clinic
Champaign, Illinois, 61822
Hope Research Institute
Chandler, Arizona, 85224
Southeast Valley Gastroenterology
Chandler, Arizona, 85224
UNC Division of Gastroenterology and Hepatology
Chapel Hill, North Carolina, 27599
Charlotte Gastroenterology & Hepatology, PLLC
Charlotte, North Carolina, 28207
Carolina Digestive Health Associates, PA
Charlotte, North Carolina, 28210
Javara Research
Charlotte, North Carolina, 28210
Carolinas Research Center
Charlotte, North Carolina, 28215
Charlottesville Medical Research
Charlottesville, Virginia, 22911
Erlanger Health Clinical Resarch
Chattanooga, Tennessee, 37403
WR-ClinSearch, LLC
Chattanooga, Tennessee, 37421
Digestive Health Specialists
Chelmsford, Massachusetts, 01824
Gastroenterology Associates of Tidewater
Chesapeake, Virginia, 23320
Clinical Research Professionals, LLC
Chesterfield, Missouri, 63005
University of Chicago Medicine
Chicago, Illinois, 60654
Curebase
Chicago, Illinois, 60656
Gastro SB Clinic
Chula Vista, California, 91910
Precision Research Institute
Chula Vista, California, 91910
Gastro Health Research
Cincinnati, Ohio, 45219
University of Cincinnati
Cincinnati, Ohio, 45267
Gastroenterology Associates Of New Jersey
Clifton, New Jersey, 07013
Gastro Center of Maryland
Columbia, Maryland, 21045
Columbus Regional Research Institute
Columbus, Georgia, 31904
Gastroenterology Associates of Mississippi
Columbus, Mississippi, 39705
ClinOhio Research Services
Columbus, Ohio, 43213
Carolina Digestive Health Associates, PA
Concord, North Carolina, 28025
Northeast GI Research Division
Concord, North Carolina, 28027
Clinical Research of South Florida, an AMR Company
Coral Gables, Florida, 33134
Northlake Gastroenterology Associates
Covington, Louisiana, 70433
GIMED Associates, Inc.
Cranston, Rhode Island, 02920
Tri-State Gastroenterology Associates
Crestview Hills, Kentucky, 41017
Allied Digestive Disease Center
Cypress, Texas, 77429
Northside Gastroenterology Associates
Cypress, Texas, 77429
Uma Mohan MD PA
Cypress, Texas, 77429
Advance Clinical Research
Dayton, Ohio, 45417
META Medical Research Institute
Dayton, Ohio, 45432
Dolphin Medical Research
Doral, Florida, 33172
Digestive Health Services
Downers Grove, Illinois, 60515
Curebase
Eagan, Minnesota, 55122
Associated Gastroenterology of Central New York
East Syracuse, New York, 13057
Alliance for Multispecialty Research, LLC
El Dorado, Kansas, 67042
El Paso Integrated Physicians Group, P.A.
El Paso, Texas, 79912
Skyline Medical Center, PC/CCT Research
Elkhorn, Nebraska, 68022
Centennial Medical Group
Elkridge, Maryland, 21075
BG Clinical Research and affiliate of The Clinical Trials Network, LLC
Encinitas, California, 92024
Diagnamics, Inc
Encinitas, California, 92024
Gastroenterology Consultants of Augusta
Evans, Georgia, 30809
Western Washington Medical Group, Inc
Everett, Washington, 98208
Verity Research
Fairfax, Virginia, 22031
Lillestol Research, LLC
Fargo, North Dakota, 58104
Plains Clinical Research Center, LLC
Fargo, North Dakota, 58104
Associated Gastroenterologists of Central New York
Fayetteville, New York, 13066
Coastal Research Institute, LLC
Fayetteville, North Carolina, 28304
AIG Digestive Disease Research
Florham Park, New Jersey, 07932
Frederick Gastroenterology Associates
Frederick, Maryland, 21701
Allied Health Clinical Research Organization, LLC
Freehold, New Jersey, 07728
Intercity Gastroenterology
Fresh Meadows, New York, 11366
Helping Hands Healthcare Group
Fullerton, California, 92831
University of Florida College of Medicine
Gainesville, Florida, 32610
Paragon RX Clinical, Inc.
Garden Grove, California, 92840
Gastro One
Germantown, Tennessee, 38138
Prime Medical Group, LLC
Gilbert, Arizona, 85296
Hope Research Institute
Glendale, Arizona, 85308
Mid-Atlantic GI Research
Greenbelt, Maryland, 20770
Medication Management LLC
Greensboro, North Carolina, 27408
Digestive Disease Research Center
Greenwood, South Carolina, 29646
Lakeview Clinical Research
Guntersville, Alabama, 35976
Hackensack Digestive Disease Associates
Hackensack, New Jersey, 07601
CMR of Greater New Haven, LLC
Hamden, Connecticut, 06517
Northlake Gastroenterology Associates
Hammond, Louisiana, 70403
Susquehanna Research Group
Harrisburg, Pennsylvania, 17110
Palmetto Research, LLC
Hialeah, Florida, 33016
Digestive Healthcare Center
Hillsborough, New Jersey, 08844
Edward Hines Jr. VA Hospital
Hines, Illinois, 60141
The Center for Gastrointestinal Disorders
Hollywood, Florida, 33021
Research Centers of America
Hollywood, Florida, 33024
CroNola LLC
Houma, Louisiana, 70360
Digestive Health Associates
Houston, Texas, 77024
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
Biopharma Informatic
Houston, Texas, 77055
Diversified Medical Practices
Houston, Texas, 77057
Houston Digestive Diseases Consultants
Houston, Texas, 77074
Memorial Hermann Surgery Center
Houston, Texas, 77084
Digestive Health Research of Southern California
Huntington Beach, California, 92647
Medical Affiliated Research Center
Huntsville, Alabama, 35801
Protenium Clinical Research Inc.
Hurst, Texas, 76054
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
United Medical Doctors
Irvine, California, 92618
Southern Therapy and Advanced Research
Jackson, Mississippi, 39216
Allied Health Clinical Research Organization
Jackson, New Jersey, 08527
Helios Clinical Research lLC
Jackson, Tennessee, 38305
The Jackson Clinic, PA
Jackson, Tennessee, 38305
The Jackson Clinic
Jackson, Tennessee, 38305
Jasper Summit Research LLC
Jasper, Alabama, 35501
East Tennessee Research Institute
Johnson City, Tennessee, 37604
Health Awareness, Inc
Jupiter, Florida, 33458
Jupiter Medical Center
Jupiter, Florida, 33458
Tri-Cities Gastroenterology
Kingsport, Tennessee, 37663
Gastrointestinal Associates, P.C.
Knoxville, Tennessee, 37909
Gastroclinic
Lafayette, Louisiana, 70503
Gastroenterology & Internal Medicine Specialist, SC, Avicenna Clinical Research
Lake Barrington, Illinois, 60010
Clinical Trials of SWLA, LLC
Lake Charles, Louisiana, 70601
Multi-Specialty Research Associates
Lake City, Florida, 32055
University Clinical Research-DeLand, LLC dba Accel Research Sites
Lake Mary, Florida, 32746
Florida Research Institute
Lakewood Rch, Florida, 34211
Gastro Care Institute
Lancaster, California, 93534
Excel Clinical Research
Las Vegas, Nevada, 89109
Wr-Crcn, Llc
Las Vegas, Nevada, 89148
South Island Gastro
Lawrence, New York, 11559
SKY Clinical Research Network Group
Lawrenceville, Georgia, 30044
Preferred Research Partners, Inc
Little Rock, Arkansas, 72211
Premier Gastroenterology
Little Rock, Arkansas, 72211
LA Gastroenterology Group
Los Angeles, California, 90004
University of Southern California
Los Angeles, California, 90033
Gastroenterology Associates of Beverly Hills
Los Angeles, California, 90048
University of Louisville Research Foundation
Louisville, Kentucky, 40202
Robley Rex VA Medical Center
Louisville, Kentucky, 40206
Blue Ridge Medical Research
Lynchburg, Virginia, 24502
Holy Family Memorial, Inc
Manitowoc, Wisconsin, 54221
East End Gastroenterology & Hepatology
Manorville, New York, 11949
Biopharma Informatic
McAllen, Texas, 78503
University Clinical Research-DeLand, LLC dba Accel Research Sites
Melbourne, Florida, 32901
Great Lakes Gastroenterology
Mentor, Ohio, 44060
Crystal Biomedical Research
Miami Lakes, Florida, 33014
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Delta Research Partners
Monroe, Louisiana, 71201
Gastroenterology Associates Of New Jersey
Montclair, New Jersey, 07042
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, 29464
Suburban Gastroenterology Ltd
Naperville, Illinois, 60540
GIMED Associates, Inc.
Narragansett, Rhode Island, 02882
Vanderbilt University Medical Center
Nashville, Tennessee, 37212
Gastrointestinal Associates of Rockland
New City, New York, 10956
Yale University
New Haven, Connecticut, 06519
Southeast Medical Research/Elms Research
North Charleston, South Carolina, 29406
Arkansas Gastroenterology
North Little Rock, Arkansas, 72117
Comprehensive Gastrointestinal Health
Northbrook, Illinois, 60062
DM Clinical Research
Oak Lawn, Illinois, 60453
Ocala GI Research, LLC
Ocala, Florida, 34471
Sarkis Clinical Trials
Ocala, Florida, 34474
Dr. Howard N. Guss and Dr. Gagan Beri
Ocean City, New Jersey, 07712
Advanced Research Institute
Ogden, Utah, 84405
Digestive Disease Specialists, Inc
Oklahoma City, Oklahoma, 73112
Midwest Regional Health Services, LLC/CCT Research
Omaha, Nebraska, 68130
Knowledge Research Center
Orange, California, 92868
Gastroenterology of Greater Orlando
Orange City, Florida, 32763
South Carolina Clinical Research LLC
Orangeburg, South Carolina, 29118
Gastroenterology Institute of Orlando
Orlando, Florida, 32807
InSite Digestive Health Care-San Gabriel
Oxnard, California, 93030
Advanced Gastroenterology Associates, LLC
Palm Harbor, Florida, 34684
Desert Oasis Healthcare Medical Group
Palm Springs, California, 92262
Palm Tree Clinical, Inc
Palm Springs, California, 92262
InSite Digestive Health Care - Gastroenterology Associates
Pasadena, California, 91105
Gastroenterology Consultants, P.A.
Pasadena, Texas, 77504
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, 19104
Einstein Medical Center Department of Digestive Disease and Transplantation
Philadelphia, Pennsylvania, 19141
GI Research Associates, LLC
Phoenix, Arizona, 85037
"Forty-Third Medical Associates Absolute Clinical Research"
Phoenix, Arizona, 85051
Pinehurst Medical Clinic
Pinehurst, North Carolina, 28374
Fanno Creek Group
Portland, Oregon, 97219
The Oregon Clinic - Gastroenterology East
Portland, Oregon, 97220
Carolina's GI Research, LLC
Raleigh, North Carolina, 27607
PMG Research of Raleigh
Raleigh, North Carolina, 27609
Gastroenterology Consultants
Reno, Nevada, 89502
Advanced Research Institute
Reno, Nevada, 89511
Gastroenterology Consultants
Reno, Nevada, 89521
The Gastroenterology Group
Reston, Virginia, 20191
GI Select Health Research, LLC
Richmond, Virginia, 23236
Smart Medical Research
Richmond Hill, New York, 11419
Quinn Healthcare
Ridgeland, Mississippi, 39157
Gastroenterology Associates Of New Jersey
Ridgewood, New Jersey, 07450
Infinite Clinical Trials
Riverdale, Georgia, 30274
Onyx Clinical Research
Rochester Hills, Michigan, 48307
Rockford Gastroenterology Associates, Ltd.
Rockford, Illinois, 61107
Meridian Clinical Research
Rockville, Maryland, 20854
Boice Willis Clinic, PA
Rocky Mount, North Carolina, 27804
Northern California Research
Sacramento, California, 95821
Covenant HealthCare
Saginaw, Michigan, 48602
Digestive Health Specialists, LLC
Saint Joseph, Missouri, 64057
PMG Research of Salisbury, LLC
Salisbury, North Carolina, 28144
Clinical Associates in Research Therapeutics of America
San Antonio, Texas, 78212
San Diego Gastroenterology Medical Associates
San Diego, California, 92103
SDG Clinical Research, Inc.
San Diego, California, 92103
Precision Research Institute
San Diego, California, 92114
Medical Associates Research Group
San Diego, California, 92123
Advanced Research Institute Granite Peaks Gastroenterology
Sandy City, Utah, 84092
WR-Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia, 30328
West Glen Gastrointestinal Consultants, P.A.
Shawnee, Kansas, 66217
Gastroenterology Partners of North Houston
Shenandoah, Texas, 77384
Louisiana Research Center, LLC
Shreveport, Louisiana, 71105
Digestive Research Alliance of Michiana
South Bend, Indiana, 46635
South Suburban Gastroenterology
South Weymouth, Massachusetts, 02190
Revive Research Institute, LLC
Southfield, Michigan, 48034
Velocity Clinical Research
Spokane, Washington, 99202
Texas Gastroenterology Associates/A1 Clinical Network
Spring, Texas, 77386
DSI Research, LLC
Springboro, Ohio, 45066
Saint Louis University GI & Hepatology Research Unit
St Louis, Missouri, 63104
Washington University School of Medicine Gastroenterology
St Louis, Missouri, 63110
Sundance Clinical Research
St Louis, Missouri, 63141
Piedmont HealthCare, PA
Statesville, North Carolina, 28625
GI Associates
Stevens Point, Wisconsin, 54482
Gastroenterology Associates of Texas, PA
Sugar Land, Texas, 77479
PPCP Division of Gastroenterology LLC
Summerville, South Carolina, 29486
Precision Clinical Research, LLC
Sunrise, Florida, 33351
Syracuse Gastro Associates
Syracuse, New York, 13210
Guardian Angel Research Center, LLC
Tampa, Florida, 33614
Teaneck Gastroenterology Associates
Teaneck, New Jersey, 07666
FOMAT Simoni AGI Medical
Thousand Oaks, California, 91360
University of Toledo Internal Medicine Clinic
Toledo, Ohio, 43606
Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc
Toluca Lake, California, 91602
Texas Gastro Consultants
Tomball, Texas, 77375
Clinical Research Institute of Michigan, LLC
Troy, Michigan, 48098
Del Sol Research Management, LLC
Tucson, Arizona, 85715
Novak Clinical Research
Tucson, Arizona, 85741
Options Health Research, LLC
Tulsa, Oklahoma, 74104
Del Sol Research Management, LLC
Tuscon, Arizona, 85715
Advanced Gastroenterology Group
Union, New Jersey, 07083
Rolphe Adult and Pediatric Medicine
Union City, Georgia, 30291
Advanced Gastroenterology
Union City, Tennessee, 38261
Frontier Clinical Research, LLC
Uniontown, Pennsylvania, 15401
Digestive Disease Medicine Of Central New York
Utica, New York, 13502
GastroCare LI
Valley Stream, New York, 11581
Curebase
Walnut Creek, California, 91789
Clinical Research of California
Walnut Creek, California, 94598
Gastrointestinal Specs Lng Is
Wantagh, New York, 11793
Avamar Gastroenterology and Center
Warren, Ohio, 44484
GI Associates
Wausau, Wisconsin, 54401
Gastroenterology Associates Of New Jersey
Wayne, New Jersey, 07470
North Jersey Gastroenterology
Wayne, New Jersey, 07470
Invocare Medical Research & Healthcare Center
West Columbia, South Carolina, 29169
Eric L. Tatar, MD
West Nyack, New York, 10994
Northshore Gastroenterology & Endoscopy Center
Westlake, Ohio, 44145
Alliance for Multispecialty Research-Wichita West
Wichita, Kansas, 67205
Kansas Gastroenterology, LLC
Wichita, Kansas, 67226
Digestive Health Research of North Texas
Wichita Falls, Texas, 76301
Tidewater Physicians Multispecialty Group Clinical Research
Williamsburg, Virginia, 23188
Wilmington Health
Wilmington, North Carolina, 28401
Trial Management Associates, LLC
Wilmington, North Carolina, 28403
PMG Research of Winston
Winston-Salem, North Carolina, 27103
Gastroenterology Associates Of New Jersey
Woodland Park, New Jersey, 07424
About this study
The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.
Read the detailed description
The LUNAR-2 test has been developed to detect malignant disease in screen-relevant patients who would otherwise undergo screening for malignant disease using invasive methodologies such as colonoscopy. The intended use of such a test would be to return a result of ctDNA detected/ ctDNA not detected in a patient eligible for average risk screening for colorectal cancer. Those patients who receive a ctDNA detected result should undergo further investigation with colonoscopy.
In order to define the performance characteristics of the test in a relevant population, this study will perform a blood draw prior to the patient undergoing the standard of care colonoscopy (and all associated preparatory medications) and retrospectively compare the performance characteristics of the LUNAR-2 test with the findings of the index colonoscopy.
Outcomes of patients at one and two-years post-procedure will be collected as secondary endpoints to investigate the possibility of incidental, non-colorectal cancer cases and interval cancers that had not reached the clinical threshold for detection at the time of the index colonoscopy.
- Conditions
- Colorectal Cancer
- Medical subject headings
- Colorectal Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity of colorectal cancer detection
Sensitivity of colorectal cancer detection
Measured: 60 days
Specificity of advanced neoplasia detection
Specificity of advanced neoplasia detection
Measured: 60 days
Secondary outcomes (3)
Positive predictive value of colorectal cancer detection
Positive predictive value of colorectal cancer detection
Measured: 60 days
Negative predictive value of colorectal cancer detection
Negative predictive value of colorectal cancer detection
Measured: 60 days
Sensitivity and specificity of advanced adenoma detection
Sensitivity and specificity of advanced adenoma detection
Measured: 60 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2019
- Study start8 Oct 2019
- Primary completion20 Mar 2024
- Study completion5 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 44,467 participants (actual)
Sponsor and investigators
- Lead sponsor
- Guardant Health, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Premier Research
- Responsible party
- Sponsor
- Investigators
- Craig Eagle, MD, Principal investigator, Guardant Health, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04136002
- Sponsor's protocol ID
- 02-GI-002
- Acronym
- ECLIPSE
- Status last verified
- May 2026
- First submitted
- 21 Oct 2019
- Last updated
- 14 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Lo YMD. Cell-free DNA for Colorectal Cancer Screening. N Engl J Med. 2024 Mar 14;390(11):1047-1050. doi: 10.1056/NEJMe2311101. No abstract available.
PubMed 38477993Chung DC, Gray DM 2nd, Singh H, Issaka RB, Raymond VM, Eagle C, Hu S, Chudova DI, Talasaz A, Greenson JK, Sinicrope FA, Gupta S, Grady WM. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening. N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
PubMed 38477985
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
- ClinicalTrials.gov ID
- NCT04136002
- Acronym / sponsor ID
- ECLIPSE / 02-GI-002
- Conditions
- Colorectal Cancer
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 44,467 participants (actual)
- Lead sponsor
- Guardant Health, Inc.Industry (pharma, biotech, devices)
- Collaborators
- Premier Research
- Study start
- 8 Oct 2019 (actual)
- Primary completion
- 20 Mar 2024 (actual)
- Study completion
- 5 Aug 2027 (estimated)
- First posted
- 23 Oct 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.
Detailed description
The LUNAR-2 test has been developed to detect malignant disease in screen-relevant patients who would otherwise undergo screening for malignant disease using invasive methodologies such as colonoscopy. The intended use of such a test would be to return a result of ctDNA detected/ ctDNA not detected in a patient eligible for average risk screening for colorectal cancer. Those patients who receive a ctDNA detected result should undergo further investigation with colonoscopy.
In order to define the performance characteristics of the test in a relevant population, this study will perform a blood draw prior to the patient undergoing the standard of care colonoscopy (and all associated preparatory medications) and retrospectively compare the performance characteristics of the LUNAR-2 test with the findings of the index colonoscopy.
Outcomes of patients at one and two-years post-procedure will be collected as secondary endpoints to investigate the possibility of incidental, non-colorectal cancer cases and interval cancers that had not reached the clinical threshold for detection at the time of the index colonoscopy.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 45 to 84 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Single cohort of patients aged between 45 and 84, with no known high risk features, undergoing routine colorectal cancer screening as standard of care.
Key inclusion criteria (5 listed)
- Subjects aged 45-84 years at time of consent
- Intended to undergo screening colonoscopy
- Considered by a physician or healthcare provider as being of 'average risk' for CRC
- Willing to consent to blood draw pre-bowel preparation administration prior to undergoing colonoscopy within 60 days of the date of the investigational blood draw
- Willing to consent to follow-up for two years as per protocol
Key exclusion criteria (13 listed)
- Undergoing colonoscopy for investigation of symptoms
- Has undergone colonoscopy within preceding 9 years
- Positive FIT/FOBT result within the previous 6 months
- Has completed Cologuard or Epi proColon testing within the previous 3 years
- History of colorectal cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sensitivity of colorectal cancer detection
Time frame: 60 days
Sensitivity of colorectal cancer detection
Specificity of advanced neoplasia detection
Time frame: 60 days
Specificity of advanced neoplasia detection
3 secondary outcomes
Positive predictive value of colorectal cancer detection
Time frame: 60 days
Negative predictive value of colorectal cancer detection
Time frame: 60 days
Sensitivity and specificity of advanced adenoma detection
Time frame: 60 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2026.
- Derived from this study: PubMed 38477993Lo YMD. Cell-free DNA for Colorectal Cancer Screening. N Engl J Med. 2024 Mar 14;390(11):1047-1050. doi: 10.1056/NEJMe2311101. No abstract available.
- Derived from this study: PubMed 38477985Chung DC, Gray DM 2nd, Singh H, Issaka RB, Raymond VM, Eagle C, Hu S, Chudova DI, Talasaz A, Greenson JK, Sinicrope FA, Gupta S, Grady WM. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening. N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
- Individual participant dataSharing planned: No
Related trials for Colorectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingObservational study
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Rectal Neoplasms
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Craig Eagle, MD principal investigator
Guardant Health, Inc.
271 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Cancer, run by Guardant Health, Inc. at 271 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 271 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensitivity of colorectal cancer detection (time frame: 60 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04136002, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.